Sermorelin Acetate
Lyophilized research reference material. Released with a per-lot Certificate of Analysis. For laboratory research use only.
- All products currently listed on this site are for research purposes ONLY.
- All products sold on this website are intended for research and identification purposes only.
- These products are not intended for human dosing, injections, or ingestion.
- Peptides are strictly for laboratory, academic, or institutional research and not for human or animal consumption.
Research background
Sermorelin is a synthetic peptide corresponding to the first 29 amino acids of growth-hormone-releasing hormone (GHRH 1-29), the minimal fully active fragment. Acting at pituitary GHRH receptors, it stimulates synthesis and pulsatile release of endogenous growth hormone, and was historically used in research and diagnostic testing of GH reserve.
Its pharmacology is well characterized; the former diagnostic product has been discontinued.
Summary of published scientific literature provided for laboratory research reference only. It is not a claim of safety, efficacy, or suitability for any use, and does not describe or recommend any human or veterinary use.
Selected references
- Walker RF. Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? Clinical Interventions in Aging. 2006;1(4):307-308.
- Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-157.
- Thorner MO, et al. Human pancreatic growth-hormone-releasing factor. The Lancet. 1983;1(8314-15):24-28.
Trademarks & attribution
Sermorelin was formerly marketed as Geref(R). That trademark is the property of its owner. Catalyst Research Labs is not affiliated with that manufacturer. Supplied as reference material only.
